Cabot Wealth Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Cabot Wealth Management’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-95,966	Closed	-$2.31M	–	151
2023 Q1	$2.31M	Sell	95,966 -88,305	-48%	-$1.11M	0.37%	64
2022 Q4	$1.95M	Buy	+184,271	New	+$1.49M	0.33%	73

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Cabot Wealth Management's PRVB Position: Q2 2023 in Review

Cabot Wealth Management sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 95,966 shares — an estimated $2.31M sold.

Cabot Wealth Management first reported a position in PRVB in Q4 2022 and held it in 2 quarters. The position peaked at $2.31M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Cabot Wealth Management reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Cabot Wealth Management sold 95,966 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $2.31M.
Cabot Wealth Management first reported a position in Provention Bio, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Cabot Wealth Management's Provention Bio, Inc. Common Stock position peaked at $2.31M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Cabot Wealth Management's 13F filing for Q2 2023, filed 13 Jul 2023.